Bankar Renuka, Suvarna Kruthi, Ghantasala Saicharan, Banerjee Arghya, Biswas Deeptarup, Choudhury Manisha, Palanivel Viswanthram, Salkar Akanksha, Verma Ayushi, Singh Avinash, Mukherjee Amrita, Pai Medha Gayathri J, Roy Jyotirmoy, Srivastava Alisha, Badaya Apoorva, Agrawal Sachee, Shrivastav Om, Shastri Jayanthi, Srivastava Sanjeeva
Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai, Maharashtra 400076, India.
Centre for Research in Nanotechnology and Sciences, Indian Institute of Technology Bombay, India.
iScience. 2021 Mar 19;24(3):102135. doi: 10.1016/j.isci.2021.102135. Epub 2021 Feb 4.
The altered molecular proteins and pathways in response to COVID-19 infection are still unclear. Here, we performed a comprehensive proteomics-based investigation of nasopharyngeal swab samples from patients with COVID-19 to study the host response by employing simple extraction strategies. Few of the host proteins such as interleukin-6, L-lactate dehydrogenase, C-reactive protein, Ferritin, and aspartate aminotransferase were found to be upregulated only in COVID-19-positive patients using targeted multiple reaction monitoring studies. The most important pathways identified by enrichment analysis were neutrophil degranulation, interleukin-12 signaling pathways, and mRNA translation of proteins thus providing the detailed investigation of host response in COVID-19 infection. Thus, we conclude that mass spectrometry-detected host proteins have a potential for disease severity progression; however, suitable validation strategies should be deployed for the clinical translation. Furthermore, the docking of potential drugs with host proteins involved in the interleukin-12 signaling pathway might aid in COVID-19 therapeutic interventions.
新冠病毒感染后发生改变的分子蛋白和信号通路仍不清楚。在此,我们对新冠患者的鼻咽拭子样本进行了一项基于蛋白质组学的全面研究,通过采用简单的提取策略来研究宿主反应。在靶向多反应监测研究中,仅在新冠阳性患者中发现少数宿主蛋白如白细胞介素-6、L-乳酸脱氢酶、C反应蛋白、铁蛋白和天冬氨酸转氨酶上调。富集分析确定的最重要信号通路是中性粒细胞脱颗粒、白细胞介素-12信号通路和蛋白质的mRNA翻译,从而为新冠病毒感染中的宿主反应提供了详细研究。因此,我们得出结论,质谱检测到的宿主蛋白具有疾病严重程度进展的潜力;然而,应采用适当的验证策略用于临床转化。此外,潜在药物与白细胞介素-12信号通路中涉及的宿主蛋白对接可能有助于新冠治疗干预。